> In free market it's also OK to cut costs as much as possible, making chair that explode and kill the user one day after the warranty expires.No, it isn't, because nobody will buy chairs from a company that does that. In a free market, no company can use the get out of jail free card of "but I was following all the regulations". Businesses have to actually meet customer needs.
And in a free market, customers can't delude themselves that Big Brother is looking out for them (even though Big Brother is not actually doing that); they know that they have to enforce quality if that's what they want. That means customers know that it's on them to be savvy enough to be able to evaluate the quality of products and services.
> That's why we have regulation: to establish the minimum standards.
That's what regulators claim, but all history shows that claim to be wrong. The end result of regulations is to reduce the quality and availability of products, not increase them. The wheelchair market described in the article is a classic example: it's regulated up one side and down the other, yet customers can't get simple things like proper footrests.
> Simple medical devices like wheelchairs (Class I or Class II) are also not super over-regulated, you don't need to do clinical trials to certify them.
Doesn't this contradict your claim that regulation is the only way to avoid exploding chairs? If you don't do clinical trials, how do you know the chairs won't explode one day after the warranty expires?
Of course the answer to this is that the regulators just, you know, look at the design of the chairs to evaluate them for certification. But customers could do the same thing for themselves, at less cost (what, you think those government regulators work for free?). So the regulations are actually adding zero value. But they're certainly not adding zero cost.
> All-in-all it'll cost you around $10m, which is not at all a moat.
So you'll be going into the wheelchair business then? Looks like there's plenty of opportunity to out-compete the current incumbents.